Lukova Paolina, Katsarov Plamen
Department of Pharmacognosy and Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Pharmaceutics. 2023 Aug 11;15(8):2126. doi: 10.3390/pharmaceutics15082126.
The main goal of modern pharmaceutical technology is to create new drug formulations that are safer and more effective. These formulations should allow targeted drug delivery, improved drug stability and bioavailability, fewer side effects, and reduced drug toxicity. One successful approach for achieving these objectives is using polymer microcarriers for drug delivery. They are effective for treating various diseases through different administration routes. When creating pharmaceutical systems, choosing the right drug carrier is crucial. Biomaterials have become increasingly popular over the past few decades due to their lack of toxicity, renewable sources, and affordability. Marine polysaccharides, in particular, have been widely used as substitutes for synthetic polymers in drug carrier applications. Their inherent properties, such as biodegradability and biocompatibility, make marine polysaccharide-based microcarriers a prospective platform for developing drug delivery systems. This review paper explores the principles of microparticle design using marine polysaccharides as drug carriers. By reviewing the current literature, the paper highlights the challenges of formulating polymer microparticles, and proposes various technological solutions. It also outlines future perspectives for developing marine polysaccharides as drug microcarriers.
现代制药技术的主要目标是创造出更安全、更有效的新型药物制剂。这些制剂应能实现靶向给药、提高药物稳定性和生物利用度、减少副作用并降低药物毒性。实现这些目标的一种成功方法是使用聚合物微载体进行药物递送。它们通过不同给药途径治疗各种疾病的效果良好。在创建药物系统时,选择合适的药物载体至关重要。在过去几十年中,生物材料因其无毒、可再生且价格低廉而越来越受欢迎。特别是海洋多糖,已被广泛用作药物载体应用中合成聚合物的替代品。其固有的特性,如生物可降解性和生物相容性,使基于海洋多糖的微载体成为开发药物递送系统的一个有前景的平台。这篇综述文章探讨了以海洋多糖为药物载体的微粒设计原理。通过回顾当前文献,文章突出了聚合物微粒制剂面临的挑战,并提出了各种技术解决方案。它还概述了将海洋多糖开发为药物微载体的未来前景。